Why Is My Recombinant Protein Insoluble?

Your expression gel shows a strong band at the expected molecular weight, but most of the target protein ends up in the pellet after cell lysis. The yield looks promising until you try to recover soluble protein. This is a common recombinant-protein production problem, but a strong band does not by itself tell you whether the protein is correctly folded, where it is accumulating, or whether refolding will work.

Start with two checks: where is the target after lysis, and at what step does it become insoluble? If it is already concentrated in the pellet, confirm its identity and integrity before deciding between expression optimization and recovery from the insoluble fraction. If it is soluble after lysis but precipitates later, investigate the purification step where solubility is lost. The right response depends on the evidence and the protein’s intended use [1,2].

For a broader overview of expression and purification stages, see Learn About Recombinant Protein Production.

In This Article

1. What Does “Insoluble Recombinant Protein” Actually Mean?
2. Why Is My Recombinant Protein Insoluble?
3. How to Diagnose the Source of Insolubility
4. Should You Optimize Expression or Refold the Protein?
5. How to Evaluate Whether Refolding Worked
6. Conclusion

1. What Does “Insoluble Recombinant Protein” Actually Mean?

A protein is often described as insoluble when it is recovered mainly in the pellet after cell disruption and centrifugation. However, the pellet is not synonymous with inclusion bodies: it may also contain cell debris, membranes, and other material that sediments under the selected conditions. The fractionation procedure and the protein’s properties affect what appears in each fraction [2,7].

Boster’s recombinant protein principle guide provides additional background on expression constructs and purification tags.

In bacterial expression, inclusion bodies are aggregates enriched in recombinant protein. They have often been associated with misfolded or inactive protein, although their composition and structural properties can vary. The important point for troubleshooting is to establish that the target protein is actually enriched in the insoluble fraction before deciding how to recover it [2,3,6].

Analyze total lysate, soluble supernatant, and insoluble pellet by SDS-PAGE using samples that represent comparable amounts of the original culture or cell material. Account for fraction volumes and dilution factors when comparing target-protein distribution. Equal loading by total protein mass answers a different question and may not show how the target’s total amount is distributed between fractions. This analysis locates the target but does not establish native folding or biological activity; molecular weight alone may not confirm identity.

2. Why Is My Recombinant Protein Insoluble?

Expression rate and folding capacity

One possible cause is that the target is produced faster than the expression host can fold, process, or otherwise accommodate it. In E. coli, high-level expression can favor aggregation and inclusion-body formation, but the outcome also depends on the target sequence, host strain, culture conditions, and construct design [2,4]. A strong expression band therefore indicates accumulation of protein-like material, not necessarily recovery of soluble, functional product.

Expression optimization may be worth testing when the target is clearly expressed but partitions mainly into the pellet. Depending on the system, researchers may compare induction strength, temperature, expression duration, host strain, or folding-support strategies. These variables should be evaluated systematically; there is no universal temperature or induction setting that makes every target soluble.

Host system, construct, and fusion tags

Solubility depends partly on the protein’s own characteristics and on the environment in which it is produced. A bacterial host may be suitable for one protein but poorly suited to another, particularly when folding requirements or post-translational processing differ. If routine optimization does not help, a different host or expression strategy may be worth considering [1,2,7].

Fusion tags can improve expression or solubility for some targets, but their effects are protein-dependent. A tag that helps the fusion protein remain soluble may also affect the target’s behavior, and tag removal can sometimes cause the target to precipitate. Tag choice should therefore be judged by the recovery and properties of the final target, not only by the amount of fusion protein produced [4,5].

For an overview of expression systems, purification, and tag options, see the recombinant protein expression service page.

Precipitation during purification

If the target is soluble after lysis but precipitates during purification, investigate the step at which solubility is lost. Changes in buffer composition, pH, ionic strength, protein concentration, or other process conditions may contribute, but the relevant cause must be established for the specific protein and process [7]. Compare samples before and after the step where precipitation begins rather than assuming the problem originated during expression.

For a broader discussion of purification methods and protein-specific considerations, see recombinant protein purification resources.

3. How to Diagnose the Source of Insolubility

The first useful experiment is a side-by-side comparison of total lysate, soluble supernatant, and insoluble pellet from the same preparation. Load samples on a basis that represents comparable amounts of the original culture or cells, and account for each fraction’s volume and dilution. Loading equal total-protein mass can be useful for comparing composition, but it does not directly show the distribution of the target’s total amount. SDS-PAGE helps locate the target; it does not establish correct folding or biological activity.

If the target is concentrated in the pellet, first confirm its identity and integrity and assess whether the pellet is likely to contain recoverable target protein. If it is initially soluble but precipitates later, focus on the step where solubility is lost. This distinction helps avoid applying expression or refolding strategies to a problem that may originate during purification.

If protein integrity is uncertain, this guide explains how protease inhibitors help limit degradation during lysis: Protease Inhibitor Cocktails.

4. Should You Optimize Expression or Refold the Protein?

When expression optimization is the better first step

Consider expression optimization when the target is being produced but a large fraction is insoluble, especially when the construct and protein identity appear sound. Adjusting expression conditions or testing another host may shift the balance between soluble and insoluble product. Fusion tags or folding-support strategies can help some proteins, but their success is target-dependent [2,4].

For available host systems and expression optimization options, see Boster’s custom recombinant protein expression service.

A useful comparison should measure both total expression and the distribution between soluble and insoluble fractions. An apparent increase in total expression is not an improvement if the amount of usable soluble target remains unchanged or falls.

When refolding may be worth testing

Refolding may be worth testing when the target is present in a recoverable insoluble fraction, its identity and integrity are established, and it can be solubilized under compatible conditions. Inclusion-body processing generally involves recovering the target-containing material, solubilizing it, and then adjusting conditions to encourage recovery of a suitable conformation. Denaturant-removal strategy, buffer composition, protein concentration, and other parameters can affect refolding yield and aggregation, so conditions need to be evaluated for the specific protein [3,6].

For a general overview of recombinant protein production and downstream recovery, see the recombinant protein production guide.

Refolding is not guaranteed to succeed. Some proteins precipitate as denaturant is removed, form aggregates, or remain soluble without recovering the required function. Refolding is protein-specific and often requires screening rather than a single standard recipe [3,6].

When to reconsider the construct or expression system

If repeated expression optimization produces little usable protein, or if refolding repeatedly yields aggregates or inactive material, revisit the construct and production strategy. A different construct boundary, fusion partner, host, or expression route may be more productive than continuing to optimize the same conditions. The appropriate choice depends on the target and the intended downstream application.

5. How to Evaluate Whether Refolding Worked

A clear solution is not enough to show that refolding succeeded. Solubility describes whether the protein remains in solution under the conditions tested; it does not establish that the protein has the intended structure or biological function.

Evaluate the recovered material against the needs of the experiment. Assess purity and integrity, and use a suitable method to examine aggregation or oligomeric state when these properties matter. If biological activity is required, test it with a relevant functional assay; structural or binding measurements may also be needed. No single readout is sufficient for every target [3,6,7].

Boster’s recombinant protein catalog provides examples of available research proteins and related production resources.

This distinction matters when comparing an expression-optimization route with an inclusion-body refolding route. The better strategy is the one that produces sufficient protein with the required quality attributes—not necessarily the one with the strongest expression band or the highest soluble fraction [3,6,7].

Conclusion

When a recombinant protein is insoluble, first establish where the target is found and when solubility is lost. Use fractionation results to distinguish an expression-stage problem from precipitation during purification. Expression optimization may help some targets, while refolding may be worth evaluating when recoverable target protein is present in an insoluble fraction.

References

[1] Beygmoradi A, Homaei A, Hemmati R, Fernandes P. Recombinant protein expression: Challenges in production and folding related matters. International Journal of Biological Macromolecules. 2023;233:123407. doi:10.1016/j.ijbiomac.2023.123407. Publisher page

[2] Bhatwa A, Wang W, Hassan YI, Abraham N, Li XZ, Zhou T. Challenges associated with the formation of recombinant protein inclusion bodies in Escherichia coli and strategies to address them for industrial applications. Frontiers in Bioengineering and Biotechnology. 2021;9:630551. doi:10.3389/fbioe.2021.630551. Full text

[3] Buscajoni L, Martinetz MC, Berkemeyer M, Brocard C. Refolding in the modern biopharmaceutical industry. Biotechnology Advances. 2022;61:108050. doi:10.1016/j.biotechadv.2022.108050. Full text copy

[4] Ki MR, Pack SP. Fusion tags to enhance heterologous protein expression. Applied Microbiology and Biotechnology. 2020;104(6):2411–2425. doi:10.1007/s00253-020-10402-8. Publisher page

[5] Silva FSR, Santos SPO, Meyer R, Silva ES, Pinheiro CS, Alcantara-Neves NM, Pacheco LGC. In vivo cleavage of solubility tags as a tool to enhance the levels of soluble recombinant proteins in Escherichia coli. Biotechnology and Bioengineering. 2021;118(11):4159–4167. doi:10.1002/bit.27912. Publisher page

[6] Nabiel A, Yosua Y, Sriwidodo S, Maksum IP. Overview of refolding methods on misfolded recombinant proteins from Escherichia coli inclusion bodies. Journal of Applied Biology & Biotechnology. 2023;11(3):47–52. doi:10.7324/JABB.2023.112204. Full text

[7] Remans K, Lebendiker M, Abreu C, Maffei M, Sellathurai S, May MM, Vaněk O, de Marco A. Protein purification strategies must consider downstream applications and individual biological characteristics. Microbial Cell Factories. 2022;21:52. doi:10.1186/s12934-022-01778-5. Full text